Second, an analysis of the available literature showed that, in the studies described so far, blood samples for the determination of kallistatin and afamin levels in patients with CAD were collected during the chronic phase of the disease or at the time of exacerbation of symptoms prior to PCI. Here, AFM is linked to coronary artery disorder.